Key Highlights

● Marchex closed its Archenia Acquisition on July 1, 2026.

● Second-quarter Revenue was $11.0 million, down from $11.7 million.

● Pro forma second-quarter revenue including Archenia was $15.5 million.

● Third-quarter pro forma revenue is guided at $16.0 million to $16.5 million.

Marchex, Inc. (NASDAQ:MCHX) closed its acquisition of Archenia on July 1, 2026, a move that reshapes its reported numbers from the third quarter onward. In its second-quarter release on August 12, 2026, the conversational analytics company reported revenue of $11.0 million, down from $11.7 million a year earlier, and gave pro forma figures that include Archenia. Investors may be weighing how much the deal could lift the business.

Latest Company Context

Second-quarter results excluded Archenia. Net loss was $408,000, or $0.01 per diluted share. Adjusted EBITDA was $743,000, including $1.0 million of reorganisation and acquisition-related costs; before those costs, it was $1.7 million. Cash and cash equivalents were $8.15 million at June 30, 2026, down from $9.94 million at December 31, 2025. The release did not mention a share buyback. The gap between reported revenue of $11.0 million and pro forma revenue of $15.5 million shows how much the acquisition changes the company's scale. Reported comparisons across periods may therefore be less informative than pro forma tables in the coming quarters.

Key Business and index Drivers

The pro forma data illustrate the potential scale of the combination. Unaudited pro forma second-quarter revenue was $15.5 million with adjusted EBITDA of $1.0 million, and pro forma first-quarter revenue was $14.4 million. For the third quarter, Marchex expects pro forma combined revenue of $16.0 million to $16.5 million and adjusted EBITDA, net of reorganisation and acquisition costs, of $2.3 million to $2.5 million.

Chairman Russell Horowitz said early customer adoption is encouraging and that the company plans selective investments in incremental sales and product development to support 2027 growth. The company said it will provide fourth-quarter and initial 2027 outlook with its third-quarter results, expected in early November 2026. These expectations are management guidance, not confirmed outcomes. With cash of roughly $8 million, integration costs and cash conversion may be important for the combined business.

What Investors Should Watch

Investors may watch the third-quarter release, expected in early November, for several items. First is whether actual results fall within the guided ranges of $16.0 million to $16.5 million in revenue and $2.3 million to $2.5 million in adjusted EBITDA. Second is the outlook for the fourth quarter and 2027, which management has said it will provide. Third is the pace of integration and the size of reorganisation costs. Fourth is the cash balance after the transaction.

Fifth is customer adoption of combined products, which management described as encouraging. Because the reported figures now include a larger entity, comparisons with earlier periods may require attention to pro forma tables. Investors may also compare the ranges with actual third-quarter results as they are reported, and look at how management describes customer adoption and pipeline in the combined business. The cash balance, which stood at roughly $8 million before the transaction closed, may be updated in the same release.

First Look at the Combined Company

Marchex has a larger revenue base after the Archenia deal and a guided step-up in profitability. The coming report may show whether integration is on track. Investors may therefore see the third-quarter report as an important checkpoint, since it should be the first to include Archenia in reported results and may bring a fuller outlook for the next year, which management has said it will provide. Integration costs are a normal feature of such deals and can weigh on short-term profit, which is why management reports adjusted EBITDA both before and after those costs. Investors may track whether the costs decline as integration proceeds.